Vertical Partial Laryngectomy
No Results
No Results
processing….
Organ preservation therapy of the larynx is offered as a functional alternative to total laryngectomy. The intended goals of preservation therapy are to circumvent permanent tracheostomy, maintain laryngeal speech, and preserve swallow function. Subtypes of operations classified as organ preservation surgery of the larynx include the following: vertical partial laryngectomy (VPL), hemilaryngectomy, endoscopic cordectomy (including procedures that use lasers), and laryngofissure with cordectomy. This article focuses on the use of VPL in the treatment of early glottic cancers.
VPL is specifically designed to treat early T1 and T2 and select T3 laryngeal cancers. Despite initial local control and cure rates comparable with those of traditional radiotherapy (RT), VPL is largely reserved for patients with recurrent or persistent T1 and T2 disease for whom such therapy has failed. The intent of this article is to elucidate the clinical indications, contraindications, and technical points of interest that should be considered in connection with the use of VPL in early glottic cancer treatment.
Open transcervical vertical laryngectomy was initially proposed by Solis-Colen in 1869 to address early T1 and T2 and select T3 glottic cancer. With the advent of primary radiotherapy in the mid 20th century, open procedures were replaced as the definitive treatment for T1 and T2 disease. This was followed by the introduction of transoral laser excision (TLE), which has been popularized over the last 10 years and is considered a viable alternative to primary RT.
Classic hemilaryngectomy, in which the surgeon removes most of the thyroid cartilage on the side of a vocal cord cancer, produces variable speech and swallowing results. This problem led to the development of multiple reconstructive techniques. Among the various techniques used, the following have received particular attention: (1) false vocal cord pulldown, (2) cartilage preservation with perichondrial/sternohyoid muscle flap reconstruction, [1] and (3) epiglottic reconstruction for defects involving the anterior commissure. [2]
More sophisticated reconstructive methods have also been described, but no matter the method, the ultimate goal is maintaining normal laryngeal function. Selection of reconstructive technique partly depends on surgeon preference but is also dictated by the extent of resection required.
VPL is primarily an operation for early glottic carcinoma.
Early carcinoma of the glottis is more common than early carcinoma of other head and neck sites because patients present with hoarseness relatively early in the course of the disease. Because radiotherapy is a well-established treatment for early glottic cancers with good oncologic and functional results, VPL is most often reserved as salvage surgery with the aim of removing the tumor with a cuff of healthy tissue. [3]
The etiology of glottic carcinoma correlates strongly with tobacco abuse, and most patients with the disease are smokers. Other etiologic factors include genetic predisposition and laryngeal papillomata. The roles of other carcinogens, such as viruses, chemicals, and inflammatory mediators, are being investigated. Some authors believe that gastroesophageal reflux disease may be a contributing factor.
Carcinoma of the larynx usually begins with dysplastic changes in the larynx, which then progress to carcinoma in situ, followed by microinvasion.
Patients with glottic carcinoma typically present with intermittent hoarseness of up to a few months’ duration. A change from intermittent to constant hoarseness indicates vocal cord paralysis. In many cases, no other clinical findings are found in early glottic carcinoma other than hoarseness and indirect laryngoscopic findings of a laryngeal lesion. Early glottic cancer can manifest as leukoplakia (most common; found during examination) or as ulceration, polypoid changes, papilloma, or erythema. Consider all of these findings suggestive, particularly if found in patients who smoke.
Vertical partial laryngectomy (VPL) is indicated as both an initial therapy and as salvage therapy for early glottic cancer (T1 and T2 stages) that has been refractive to primary radiotherapy or transoral laser excision. In select cases, T3 lesions may also be addressed with this family of operations. However, it may not be appropriate in cases of recurrent glottic carcinomas, as they are often understaged and present with multiple foci of tumor throughout the larynx.
For T1 lesions that do not involve the anterior commissure, laser cordectomy can be performed. The false vocal cord reconstruction is then feasible using imbrication laryngoplasty. This operation facilitates false vocal cord reconstruction while maintaining the bulk of the neocord by transferring vascularized innervated false cord to oppose the contralateral true vocal cord. T2 lesions classified as such by impaired mobility are also appropriately addressed in this manner.
For T2 lesions that involve the supraglottis, the false vocal cord usually cannot be pulled down. If a VPL is selected, a different reconstruction technique, such as the perichondrial/sternohyoid muscle flap procedure or a muscle/free mucosal flap procedure, should be considered.
The larynx is located within the anterior aspect of the neck, anterior to the inferior portion of the pharynx and superior to the trachea. Its primary function is to protect the lower airway by closing abruptly upon mechanical stimulation, thereby halting respiration and preventing the entry of foreign matter into the airway. Other functions of the larynx include the production of sound (phonation), coughing, the Valsalva maneuver, and control of ventilation, and acting as a sensory organ.
For more information about the relevant anatomy, see Larynx Anatomy, Vocal Cord and Voice Box Anatomy, and Thyroid Anatomy.
See also Intraoperative details in the Treatment section.
Cancer that involves the anterior commissure, or is close to the Broyle ligament, makes tumor invasion of the thyroid cartilage more accessible. This risk has prompted some authors to question employing vertical partial laryngectomy (VPL) for such lesions in favor of a different organ preservation technique such as supracricoid partial laryngectomy (SCPL) with cricohyoidoepiglottopexy (CHEP) or cricohyoidopexy (CHP). Although voice results following SCPL are predictably worse than after VPL, some studies have shown the local control rates following SCPL are perhaps better for selected T2 and T3 lesions of the glottis. Each case should be individualized for the patient’s particular tumor and preoperative function.
Some absolute contraindications to VPL exist. These include large T3 or any T4 lesions, arytenoid fixation, thyroid cartilage invasion, interarytenoid invasion, cricoarytenoid joint invasion, subglottic extension involving the cricoid cartilage, lesions that extend outside the larynx, and pre-epiglottic space invasion.
Because of the relative lack of lymphatics in the glottic division of the larynx, glottic cancers tend to metastasize only in advanced stages. A finding of nodal disease therefore indicates more advanced disease and is a relative contraindication to VPL.
Ouyang D, Liu TR, Chen YF, Wang J. Modified frontolateral partial laryngectomy operation: combined muscle-pedicle hyoid bone and thyrohyoid membrane flap in laryngeal reconstruction. Cancer Biol Med. 2013 Jun. 10(2):103-9. [Medline]. [Full Text].
Luna-Ortiz K, Campos-Ramos E, Villavicencio-Valencia V, Contreras-Buendía M, Pasche P, Gómez AH. Vertical partial hemilaryngectomy with reconstruction by false cord imbrication. ANZ J Surg. 2010 May. 80(5):358-63. [Medline].
Philippe Y, Espitalier F, Durand N, Ferron C, Bardet E, Malard O. Partial laryngectomy as salvage surgery after radiotherapy: oncological and functional outcomes and impact on quality of life. A retrospective study of 20 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Feb. 131(1):15-9. [Medline].
Zbaren P, Christe A, Caversaccio MD, et al. Pretherapeutic staging of recurrent laryngeal carcinoma: clinical findings and imaging studies compared with histopathology. Otolaryngol Head Neck Surg. 2007 Sep. 137(3):487-91. [Medline].
Yiotakis J, Stavroulaki P, Nikolopoulos T, et al. Partial laryngectomy after irradiation failure. Otolaryngol Head Neck Surg. 2003 Feb. 128(2):200-9. [Medline].
Brumund KT, Gutierrez-Fonseca R, Garcia D, et al. Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol. 2005 Apr. 114(4):314-22. [Medline].
Kardasz-Ziomek M, Scierski W, Namyslowski G. Operation treatment results of laryngeal cancer in different types of partial laryngectomy based on own material. Otolaryngol Pol. 2014 September – October. 68(5):233-238. [Medline].
Bailey BJ. Head and Neck Surgery-Otolaryngology Atlas. Baltimore, Md:. Lippincott Williams & Wilkins. 1996.
Bailey BJ, Calcaterra TC. Vertical, subtotal laryngectomy and laryngoplasty. Review of experience. Arch Otolaryngol. 1971 Mar. 93(3):232-7. [Medline].
Brasnu D, Laccourreye O, Weinstein G, et al. False vocal cord reconstruction of the glottis following vertical partial laryngectomy: a preliminary analysis. Laryngoscope. 1992 Jun. 102(6):717-9. [Medline].
Davis RK, Hadley K, Smith ME. Endoscopic vertical partial laryngectomy. Laryngoscope. 2004 Feb. 114(2):236-40. [Medline].
Kadish SP. Can I treat this small larynx lesion with radiation alone? Update on the radiation management of early (T1 and T2) glottic cancer. Otolaryngol Clin North Am. 2005 Feb. 38(1):1-9, vii. [Medline].
Kambic V, Radsel Z, Smid L. Laryngeal reconstruction with epiglottis after vertical hemilaryngectomy. J Laryngol Otol. 1976 May. 90(5):467-73. [Medline].
Kim MS, Joo YH, Cho KJ, Park JO, Sun DI. A classification system for the reconstruction of vertical hemipharyngolaryngectomy for hypopharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2011 Jan. 137(1):88-94. [Medline].
Laccourreye O, Weinstein G, Brasnu D, et al. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol. 1991 Jan. 100(1):68-71. [Medline].
Pleet L, Ward PH, DeJager HJ, et al. Partial laryngectomy with imbrication reconstruction. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol. 1977 Sep-Oct. 84(5):ORL882-9. [Medline].
Vachin F, Hans S, Atlan D, et al. [Long term results of exclusive chemotherapy for glottic squamous cell carcinoma complete clinical responders after induction chemotherapy]. Ann Otolaryngol Chir Cervicofac. 2004 Jun. 121(3):140-7. [Medline].
Yeager LB, Grillone GA. Organ preservation surgery for intermediate size (T2 and T3) laryngeal cancer. Otolaryngol Clin North Am. 2005 Feb. 38(1):11-20, vii. [Medline].
Christopher Klem, MD Attending Surgeon, Chief, Head and Neck Oncologic Surgery, Microvascular Reconstructive Surgery, Assistant Chief, Otolaryngology–Head and Neck Surgery Service, Tripler Army Medical Center
Christopher Klem, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Head and Neck Society, American Medical Association, American Society for Reconstructive Microsurgery
Disclosure: Nothing to disclose.
Jessica J Peck, MD Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Georgia Regents University
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference
Disclosure: Received salary from Medscape for employment. for: Medscape.
Karen H Calhoun, MD, FACS, FAAOA Professor, Department of Otolaryngology-Head and Neck Surgery, Ohio State University College of Medicine
Karen H Calhoun, MD, FACS, FAAOA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Head and Neck Society, Association for Research in Otolaryngology, Southern Medical Association, American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Rhinologic Society, Society of University Otolaryngologists-Head and Neck Surgeons, Texas Medical Association
Disclosure: Nothing to disclose.
Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;Preacute Population Health Management;The Physicians Edge<br/>Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa<br/> Received stock from RxRevu; Received ownership interest from Cerescan for consulting; for: Rxblockchain;Bridge Health.
David J Terris, MD, FACS Porubsky Professor and Chairman, Department of Otolaryngology, Medical College of Georgia, Georgia Regents University
David J Terris, MD, FACS is a member of the following medical societies: American Association for the Advancement of Science, Federation of American Societies for Experimental Biology, International Association of Endocrine Surgeons, Alpha Omega Alpha, Triological Society, Radiation Research Society, American Academy of Otolaryngology-Head and Neck Surgery, American Bronchoesophagological Association, American College of Surgeons, American Head and Neck Society, Phi Beta Kappa, Society of University Otolaryngologists-Head and Neck Surgeons
Disclosure: Nothing to disclose.
Christopher H Rassekh, MD Director, Associate Professor, Department of Otolaryngology-Head and Neck Surgery, West Virginia University
Christopher H Rassekh, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Cancer Society, American Head and Neck Society, American Medical Association, American Rhinologic Society, American Society for Head and Neck Surgery, and West Virginia State Medical Association
Disclosure: Nothing to disclose.
Jon Robitschek, MD Resident Physician, Department of Otolaryngology, Tripler Army Medical Center
Jon Robitschek, MD is a member of the following medical societies: Alpha Omega Alpha
Disclosure: Nothing to disclose.
Vertical Partial Laryngectomy
Research & References of Vertical Partial Laryngectomy|A&C Accounting And Tax Services
Source
0 Comments